{"id":"W2051243940","doi":"10.1111/dom.12188","title":"Empagliflozin improves glycaemic and weight control as add‐on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24‐week, randomized, placebo‐controlled trial","year":2013,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":383,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Empagliflozin; Metformin; Pioglitazone; Placebo; Medicine; Type 2 diabetes; Tolerability; Internal medicine; Clinical endpoint; Urology; Diabetes mellitus; Adverse effect; Randomized controlled trial; Gastroenterology; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009632438,0.0007344482,0.003054862,0.0006350843,0.0001540515,0.0001583842,0.0001755159,0.0002151376,0.0002442907],"category_scores_gemma":[0.0006251048,0.0004302123,0.000237648,0.0004765852,0.0002291041,0.0004345422,0.0001004246,0.0002988153,0.00009123851],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008891771,"about_ca_system_score_gemma":0.00009307855,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001137754,"about_ca_topic_score_gemma":0.00002258373,"domain_scores_codex":[0.9964781,0.0003665866,0.0007834418,0.0008263235,0.0005789395,0.0009665661],"domain_scores_gemma":[0.9976037,0.0008280604,0.0002607218,0.0005247347,0.0002349758,0.0005478734],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9508849,0.002592302,0.01552114,0.0001321485,0.002810473,0.0000106617,0.0007387063,0.00000334299,0.0004203028,0.0003052213,0.0008157706,0.02576504],"study_design_scores_gemma":[0.9365845,0.005688675,0.05202148,0.0001979842,0.001447623,2.888326e-7,0.00008536812,0.0002475314,0.0006000688,0.0003489496,0.002236434,0.0005410432],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.974837,0.005533014,0.000006032947,0.0004727766,0.0005191786,0.01794601,0.00002714158,0.0001006598,0.0005581555],"genre_scores_gemma":[0.9897677,0.0008733971,0.0004703104,0.00292682,0.0002651197,0.003256867,0.00007533028,0.00007396014,0.002290467],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03650034,"threshold_uncertainty_score":0.999815,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006671166235841569,"score_gpt":0.2134640705234327,"score_spread":0.2067929042875911,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}